Literature DB >> 10231253

Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model.

P Sasieni1, J Adams.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10231253      PMCID: PMC27862          DOI: 10.1136/bmj.318.7193.1244

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Mortality trends by cause of death in England and Wales 1980-94: the impact of introducing automated cause coding and related changes in 1993.

Authors:  C Rooney; T Devis
Journal:  Popul Trends       Date:  1996

2.  Cancer of the cervix: a sexually transmitted infection?

Authors:  V Beral
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

3.  Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.

Authors:  P D Sasieni; J Cuzick; E Lynch-Farmery
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  3 in total
  39 in total

1.  Effect of screening on cervical cancer mortality in England and Wales. Interactive effects and causation must be considered.

Authors:  W C Leung
Journal:  BMJ       Date:  1999-08-28

2.  Screening and mortality from cervical cancer. Does screening really reduce mortality?

Authors:  J S Vaidya; M Baum
Journal:  BMJ       Date:  1999-09-04

3.  Routine audit is an ethical requirement of screening.

Authors:  P Sasieni; J Cuzick
Journal:  BMJ       Date:  2001-05-12

Review 4.  Communicating the benefits and harms of cancer screening.

Authors:  Lindsay J L Forbes; Amanda J Ramirez
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

5.  Self-reported willingness to have cancer screening and the effects of sociodemographic factors.

Authors:  Nancy R Kressin; Meredith Manze; Stefanie L Russell; Ralph V Katz; Cristina Claudio; B Lee Green; Min Qi Wang
Journal:  J Natl Med Assoc       Date:  2010-03       Impact factor: 1.798

6.  An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany.

Authors:  Sara K Sheriff; K Ulrich Petry; Hans Ikenberg; Geoffrey Crouse; Peter D Mazonson; Christopher C Santas
Journal:  Eur J Health Econ       Date:  2007-02-17

7.  Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.

Authors:  A E Raffle; B Alden; M Quinn; P J Babb; M T Brett
Journal:  BMJ       Date:  2003-04-26

8.  Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Authors:  Gabriel M Leung; Pauline P S Woo; Sarah M McGhee; Annie N Y Cheung; Susan Fan; Oscar Mang; Thuan Q Thach; Hextan Y S Ngan
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

9.  Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort.

Authors:  R J Taylor; S L Morrell; H A Mamoon; G V Wain
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

10.  Randomised controlled trial of the effect of evidence based information on women's willingness to participate in cervical cancer screening.

Authors:  P Adab; T Marshall; A Rouse; B Randhawa; H Sangha; N Bhangoo
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.